Titan Pharmaceuticals
TTNP
#11031
Rank
HK$48.08 M
Marketcap
HK$36.15
Share price
-3.76%
Change (1 day)
17.09%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2023 (TTM): -HK$4.47

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.42. In 2022 the company made an earnings per share (EPS) of -HK$6.04 an increase over its 2021 EPS that were of -HK$7.06.

EPS history for Titan Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$4.47-26.02%
2022-HK$6.04-14.44%
2021-HK$7.06-83.46%
2020-HK$42.67-81.27%
2019-HK$227.88-49%
2018-HK$446.81-53.11%
2017-HK$952.93-361.29%
2016HK$364.70-146.98%
2015-HK$776.30279.31%
2014-HK$204.66-120.57%
2013HK$995.08-153.41%
2012-HK$1,863-7.69%
2011-HK$2,018160%
2010-HK$776.310%
2009-HK$776.31
2007-HK$3,183-2.38%
2006-HK$3,260-39.13%
2005-HK$5,357-16.87%
2004-HK$6,443-22.43%
2003-HK$8,3065.94%
2002-HK$7,84160.32%
2001-HK$4,891-12.5%
2000-HK$5,5892.86%
1999-HK$5,434-13.58%
1998-HK$6,288-2800%
1997HK$232.89-101.76%
1996-HK$13,217

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.42-252.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.17-219.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$36.31 5.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-HK$1.57-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.80-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.11-0.91%๐Ÿ‡บ๐Ÿ‡ธ USA